| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.436 | 48.492 | 63.592 | 64.360 | 61.701 | 115.073 | 125.530 | 145.369 | 123.076 | 247.998 |
| Total Income - EUR | 44.436 | 48.492 | 63.592 | 64.360 | 66.099 | 115.440 | 125.533 | 145.369 | 123.279 | 247.998 |
| Total Expenses - EUR | 21.894 | 34.860 | 36.007 | 34.507 | 63.936 | 55.187 | 48.224 | 65.631 | 75.919 | 109.658 |
| Gross Profit/Loss - EUR | 22.542 | 13.632 | 27.584 | 29.853 | 2.163 | 60.253 | 77.309 | 79.738 | 47.361 | 138.339 |
| Net Profit/Loss - EUR | 21.209 | 13.147 | 26.948 | 29.209 | 1.504 | 59.330 | 76.068 | 78.284 | 46.128 | 116.027 |
| Employees | 3 | 3 | 4 | 4 | 3 | 4 | 4 | 5 | 5 | 5 |
Check the financial reports for the company - Duomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.508 | 2.700 | 1.672 | 453 | 45.935 | 75.803 | 61.533 | 49.023 | 36.219 | 26.693 |
| Current Assets | 52.967 | 62.991 | 57.028 | 87.608 | 54.068 | 69.476 | 157.026 | 66.998 | 50.500 | 102.225 |
| Inventories | 4.049 | 4.170 | 3.088 | 3.671 | 3.158 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.271 | 283 | 439 | 91 | 6.293 | 5.667 | 11.736 | 58.255 | 15.959 | 9.419 |
| Cash | 39.647 | 58.539 | 53.500 | 83.846 | 44.617 | 63.808 | 145.290 | 8.744 | 34.541 | 92.805 |
| Shareholders Funds | 53.532 | 30.505 | 56.937 | 85.102 | 86.251 | 143.946 | 216.821 | 100.706 | 81.589 | 116.746 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.943 | 35.186 | 1.762 | 2.959 | 13.752 | 1.333 | 1.860 | 15.681 | 5.131 | 12.172 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Duomedica Srl